GLP-1 (5mg)

A synthetic peptide analog engineered to selectively bind and activate glucagon-like peptide-1 receptors. The molecule features modifications to its amino acid sequence that confer resistance to enzymatic degradation, significantly extending its half-life compared to native peptides. Functions through G-protein coupled receptor activation, triggering intracellular signaling cascades that modulate glucose-dependent insulin secretion pathways and appetite regulation centers.